Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults
Clinical trial NCT00510874 · COMPLETED
Trial details
- NCT number
- NCT00510874
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-28
- Primary completion
- 2008-06-17
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.